Peptidomics is a qualitative and quantitative strategy used to identify and analyze endogenous peptides within biological systems. A range of methodologies contributes to this approach, including:
Together, these methods help construct a comprehensive profile of the peptidome: the complete set of amino acid oligomers present in a biological sample.
Peptides serve as reflections of a cell’s metabolic state, as they are primarily produced by proteases, which are regulated by various signaling pathways. Additionally, some peptides can originate from short open reading frames located on DNA or RNA.
As active compounds, peptides play crucial physiological and pathophysiological roles; they actively participate in numerous biological processes, such as:
The unique fingerprint provided by a peptidomic profile can highlight physiological differences between individuals and reveal how an individual responds to chemical challenges, such as drug action. This makes peptidomics highly valuable for both basic and medical research.
Discover how early analytical strategies enabled the structural characterization of human CGRP, a potent vasodilator. This foundational Nature paper offers valuable insights into peptide analysis techniques still relevant today.
Pharmaceutical and biotech companies utilize peptidomic fingerprinting to identify biomarkers, molecules characteristic of diseases such as cancer, which can facilitate early diagnosis and aid in validating new drugs. Peptidomics is also instrumental in the discovery of new therapeutics, including antimicrobial and antiviral molecules.
The momentum behind peptide-based therapeutics continues to grow. Whether developing a novel antimicrobial peptide or validating a peptide biomarker, BioPharmaSpec provides tailored analytical strategies that support streamlined and efficient drug development from sample screening to deep structural analysis in accordance with ICH Q6B guidelines.
The chemical diversity inherent in naturally occurring amino acids leads to a vast array of peptides, each with unique physicochemical properties in terms of the structure, conformation, size, charge, and hydrophobicity, despite their relatively short length sequences. Additionally, amino acids can be modified by post-translational modifications (PTMs), such as:
These post-translational modifications add significant complexity to the peptidome profile. Understanding the full landscape of PTMs, sequence variants, and folding issues is increasingly important. BioPharmaSpec applies extensive expertise in peptide characterization, utilizing a broad portfolio of biochemical and biophysical methods to help bio/pharmaceutical companies navigate these complexities.
Despite peptidomics being a multidisciplinary field, mass spectrometry remains a key analytical tool due to its high sensitivity and capability to generate informative fragment ions that facilitate accurate peptide identification. A prominent example is the use of LC-MS and LC-MS/MS workflows, which enable the on-line separation and identification of peptides from complex mixtures, providing insightful data into the complete peptidome of a biological system.
Tailored sample preparation protocols improve peptide accessibility, while enrichment or isolation procedures targeting peptides with specific amino acids or PTMs (e.g., phosphorylation, glycosylation) allow for the detection of low-abundance peptide species. Rapid sample preparation is essential to prevent distortion of the peptidome by ongoing cellular processes occurring after sample collection, especially when studying bioactive peptides.
Quantitative data obtained through methods such as single or multi-reaction monitoring (SRM or MRM), label-free analysis, or labeling techniques, further enhances bioinformatic analysis of peptidome data. Advanced software platforms, extensive databases, sophisticated algorithms, deep learning strategies, and rigorous statistical analyses are employed for data interpretation. However, manual interpretation may still be necessary, particularly for peptides with complex structural features.
At BioPharmaSpec, our experts are highly skilled in manually analyzing peptide spectra that fall outside the capabilities of automated software, such as those involving disulfide bridges or other challenging modifications.
A comprehensive peptidomic analysis provides a snapshot of peptide identities and quantities, forming the foundation for further investigation. Follow-up experiments may include:
BioPharmaSpec’s expert analytical services supports drug developers at critical stages, particularly in the characterization and quantification of complex PTMs like glycosylation, lipidation, and disulfide bridging.
The high dynamic range of peptides within a peptidome presents challenges, especially in detecting low-abundance species. Effective enrichment protocols and fractionation of complex samples may be necessary for optimal analysis. Sampling must be unbiased, rapid, and free from adverse impacts such as induced proteolysis, which could compromise peptide data. Minimizing material loss and proteolytic activity during sample preparation is critical.
State-of-the-art analytics and data processing are essential, and BioPharmaSpec’s experience with mass spectrometry-based workflows and data analysis supports drug developers to address the complexities of peptide-based therapeutics.
Integrating peptidomic data with other “omics” technologies, though resource-intensive, can aid data interpretation to gain insight into biological questions.
Ongoing advancements in instrumentation, algorithms, deep learning, database quality, and interpretation tools continue to enhance our understanding of peptidomic data. These improvements are poised to expand biological knowledge and drive the discovery of new drugs and medicines.
From identifying low-abundance peptides and novel PTMs to confirming folding and structural integrity, BioPharmaSpec’s peptidomics workflows offer clients the analytical clarity required for confident, informed decision-making during the drug development process.
Whether you're navigating early-stage development or preparing for regulatory submission, BioPharmaSpec offers expert-driven peptide analysis services to help you meet structural characterization requirements with confidence.
Contact our scientists today to discuss your peptide project and receive a tailored analytical strategy.
